Fingerprint
Dive into the research topics of 'Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: A randomised, double-blind, phase III equivalence study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically